SAB Biotherapeutics, Inc.
SABS
$3.94
-$0.21-5.06%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -12.89% | 1,840.64% | -55.54% | -38.10% | -31.71% |
| Total Receivables | 69.07% | -- | -- | -61.09% | -43.30% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 91.34% | -48.92% | 4.95% | 15.06% | 45.96% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -10.79% | 1,116.97% | -42.88% | -31.50% | -26.88% |
|
|
|||||
| Total Current Assets | -10.79% | 1,116.97% | -42.88% | -31.50% | -26.88% |
| Net Property, Plant & Equipment | -0.17% | -4.73% | -4.54% | 7.29% | -3.97% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4,299.27% | -70.28% | -7.18% | -6.70% | -6.28% |
| Total Assets | -5.80% | 508.87% | -20.96% | -13.75% | -17.85% |
|
|
|||||
| Total Accounts Payable | 6.46% | 12.68% | 4.05% | 48.72% | 30.66% |
| Total Accrued Expenses | -3.88% | -3.41% | 17.11% | 10.65% | -20.45% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -3.73% | 2.61% | -10.58% | 32.69% | 54.72% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -1.04% | 1.09% | 10.61% | 20.98% | -9.49% |
|
|
|||||
| Total Current Liabilities | -1.04% | 1.09% | 10.61% | 20.98% | -9.49% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -3.84% | -4.70% | -4.39% | 47.93% | -3.46% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 136.60% | 20.26% | 46.32% | -78.82% | 56.49% |
| Total Liabilities | 16.01% | 1.44% | 8.38% | -8.30% | 7.88% |
|
|
|||||
| Common Stock & APIC | 1.20% | 68.47% | 0.40% | 0.39% | 0.42% |
| Retained Earnings | -17.93% | 32.58% | -7.82% | -4.19% | -10.10% |
| Treasury Stock & Other | 2.12% | 1.57% | 1.70% | 0.42% | -3.43% |
| Total Common Equity | -8.23% | 1,273.76% | -43.87% | -17.57% | -29.63% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -8.23% | 1,273.76% | -43.87% | -17.57% | -29.63% |
| Total Preferred Equity | 0.00% | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -8.23% | 1,273.76% | -43.87% | -17.57% | -29.63% |
|
|
|||||